1. Home
  2. TCX vs GALT Comparison

TCX vs GALT Comparison

Compare TCX & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tucows Inc.

TCX

Tucows Inc.

HOLD

Current Price

$21.34

Market Cap

233.3M

Sector

Technology

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$3.88

Market Cap

261.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCX
GALT
Founded
1992
2000
Country
Canada
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.3M
261.1M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
TCX
GALT
Price
$21.34
$3.88
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.50
AVG Volume (30 Days)
24.5K
811.0K
Earning Date
02-12-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$384,728,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8.03
N/A
52 Week Low
$13.27
$1.07
52 Week High
$24.35
$7.13

Technical Indicators

Market Signals
Indicator
TCX
GALT
Relative Strength Index (RSI) 48.02 33.36
Support Level $21.72 $3.90
Resistance Level $22.75 $4.35
Average True Range (ATR) 0.98 0.47
MACD -0.15 -0.14
Stochastic Oscillator 6.00 9.29

Price Performance

Historical Comparison
TCX
GALT

About TCX Tucows Inc.

Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. Geographically company operates in USA, Canada and Europe.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: